위궤양 시장 규모는 향후 수년간 강력한 성장세를 보일 것으로 예상되며, 2029년에는 연평균 5.5%의 연평균 복합 성장률(CAGR)로 56억 4,000만 달러에 달할 것으로 예상됩니다. 예측 기간 중의 성장은 진단 기술 향상, 건강에 해로운 식습관 개선, 양성자 펌프 억제제(PPI)를 포함한 치료 옵션의 발전, 질병 부담 증가에 기여하는 고령화, 신흥 시장의 의료 인프라 확대 등에 기인하는 것으로 추정됩니다. 예측 기간 중 주요 동향으로는 유효성을 높이기 위한 병용요법으로의 전환, 최소침습적 치료법에 대한 선호도 증가, 질병 관리에 디지털 헬스 솔루션의 통합, 일반의약품(OTC) 궤양 치료제에 대한 수요 증가, 궤양 치료에 대한 개인별 맞춤 치료 접근법 확대 등이 있습니다.
노인 인구 증가는 향후 수년간 위궤양 시장의 성장을 촉진할 것으로 예상됩니다. 노령 인구는 일반적으로 65세 이상의 노인을 의미하며, 노화에 따른 특유의 건강 문제에 직면해 있습니다. 이러한 증가의 주요 원인은 세계 여러 지역의 출산율 감소와 평균 수명 연장으로 이어진 헬스케어의 발전이 주요 원인으로 꼽힙니다. 위궤양은 합병증 위험을 증가시키는 비스테로이드성 항염증약의 빈번한 사용과 점막 보호 기능의 저하로 인해 노년층에서 더 많이 발생합니다. 예를 들어 2024년 1월 미국 비영리단체인 인구문제연구소(PRB)는 65세 이상 미국인 인구가 2022년 5,800만 명에서 2050년 8,200만 명으로 47% 증가할 것으로 예상했습니다. 또한 이 연령대가 전체 인구에서 차지하는 비중은 17%에서 23%로 상승할 것으로 예상되어 미국의 고령화 추세가 두드러지게 나타날 것으로 예상됩니다. 이러한 예측은 다양한 분야에서 노년층의 헬스케어 니즈에 대응해야 할 필요성이 증가하고 있음을 강조합니다. 이처럼 노인 인구 증가는 위궤양 시장의 성장을 촉진하고 있습니다.
위궤양 시장의 주요 기업은 치료 효과를 높이고 부작용을 최소화하기 위해 새로운 제형과 같은 혁신적인 제품 개발에 주력하고 있습니다. 신제형이란 유효성, 안전성, 환자의 복약 순응도를 높이기 위해 유효 성분, 약물전달, 제형의 새로운 조합을 통해 의약품을 만드는 것을 말합니다. 예를 들어 2024년 6월 인도 제약회사 아쿠무스 제약(Akumus Drugs and Pharmaceuticals)은 라베프라졸+레보설피리드 SR 캡슐을 출시했습니다. 이 캡슐은 위식도역류질환(GERD) 및 기타 소화관(GIT) 질환과 같은 증상을 개선하도록 설계되었습니다. 양성자 펌프 억제제와 프로키네틱 제제의 조합으로 GERD 및 위궤양과 같은 위장 장애를 효과적으로 치료합니다. 이 제제는 위산 분비를 감소시킬 뿐만 아니라 위 운동을 개선하고 속쓰림, 소화불량 등의 증상을 종합적으로 완화합니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나바이러스 및 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 위궤양 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 용도 산업의 분석
- 세계의 위궤양 시장 : 성장률 분석
- 세계의 위궤양 시장 실적 : 규모와 성장, 2019-2024
- 세계의 위궤양 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 위궤양 TAM(Total Addressable Market)
제6장 시장 세분화
- 세계의 위궤양 시장 : 약제 클래스별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 프로톤 펌프 저해제(PPI)
- H2 길항제
- 제산제
- 항생제
- 세포 보호제
- 기타 약물 클래스
- 세계의 위궤양 시장 : 진단별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 변검사
- 내시경검사
- 영상 검사
- 컴퓨터 단층촬영(CT) 스캔
- X선
- 혈액검사
- 기타 진단
- 세계의 위궤양 시장 : 투여 경로별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 경구
- 비경구
- 기타 투여 경로
- 세계의 위궤양 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 병원 약국
- 소매 약국
- 온라인 약국
- 기타 유통 채널
- 세계의 위궤양 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 병원
- 전문 클리닉
- 홈케어
- 기타 최종사용자
- 세계의 위궤양 시장 프로톤 펌프 저해제(PPI)의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- Omeprazole
- Lansoprazole
- Pantoprazole
- Esomeprazole
- Rabeprazole
- 세계의 위궤양 시장 H2 길항제의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- Ranitidine
- Famotidine
- Cimetidine
- Nizatidine
- 세계의 위궤양 시장 제산제의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 탄산칼슘
- 수산화마그네슘
- 수산화 알루미늄
- 중탄산나트륨
- 세계의 위궤양 시장 항생제의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- Amoxicillin
- Clarithromycin
- Metronidazole
- Tetracycline
- 세계의 위궤양 시장 세포 보호제의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- Sucralfate
- Misoprostol
- Bismuth Subsalicylate
- 세계의 위궤양 시장, 기타 약물 클래스의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 프로스타글란딘 유사체
- 소화관 운동 촉진제
- 허브 요법과 대체요법
- 병용요법
제7장 지역별·국가별 분석
- 세계의 위궤양 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 위궤양 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 위궤양 시장 : 경쟁 구도
- 위궤양 시장 : 기업 개요
- Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
- AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
- Abbott Laboratories
- Novartis AG
- GlaxoSmithKline plc
- Takeda Pharmaceutical Co. Ltd
- Amgen Inc.
- Boehringer Ingelheim
- Viatris Inc.
- Daiichi Sankyo Company Limited
- Eisai Co. Ltd
- Cadila Pharmaceuticals
- Dr. Reddy's Laboratories Ltd.
- Hikma Pharmaceuticals PLC
- Lupin Limited
- Yuhan Corporation
- Daewoong Pharmaceutical Co. Ltd
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 위궤양 시장 2029 : 새로운 기회를 제공하는 국가
- 위궤양 시장 2029 : 새로운 기회를 제공하는 부문
- 위궤양 시장 2029 : 성장 전략
제36장 부록
KSA
Gastric ulcers, also known as peptic ulcers, are open sores on the stomach's inner lining caused by the corrosive action of stomach acid. They often result in burning stomach pain, indigestion, and discomfort. These ulcers typically arise from an imbalance between stomach acid, the enzyme pepsin, and the protective mucosal barrier lining the stomach and duodenum.
The primary drug classes used to treat gastric ulcers include proton pump inhibitors (PPIs), H2 antagonists, antacids, antibiotics, cytoprotective agents, and others. Proton pump inhibitors are medications that reduce stomach acid production by inhibiting the proton pump enzyme in gastric cells. Gastric ulcers can be diagnosed through stool tests, endoscopies, imaging tests, computed tomography (CT) scans, X-rays, blood tests, and other methods. Treatment routes include oral and parenteral administration, among others. Distribution channels primarily consist of hospital pharmacies, retail pharmacies, and online pharmacies, and the treatments are utilized by various end-users such as hospitals, specialty clinics, and homecare settings.
The gastric ulcers market research report is one of a series of new reports from The Business Research Company that provides gastric ulcers market statistics, including gastric ulcers industry global market size, regional shares, competitors with a gastric ulcers market share, detailed gastric ulcers market segments, market trends and opportunities, and any further data you may need to thrive in the gastric ulcers industry. This gastric ulcers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The gastric ulcers market size has grown strongly in recent years. It will grow from $4.29 billion in 2024 to $4.54 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to the rising prevalence of helicobacter pylori infections, increasing use of nonsteroidal anti-inflammatory drugs (NSAIDs), growing geriatric population globally, rising awareness campaigns for gastric ulcer prevention and increasing incidence of stress-related disorders.
The gastric ulcers market size is expected to see strong growth in the next few years. It will grow to $5.64 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to improvements in diagnostic techniques, adoption of unhealthy dietary habits, advancements in treatment options, including proton pump inhibitors (PPIs), aging population contributing to higher disease burden and expansion of healthcare infrastructure in emerging markets. Major trends in the forecast period include shift towards combination therapies for enhanced efficacy, growing preference for minimally invasive treatment procedures, integration of digital health solutions in disease management, rising demand for over-the-counter (OTC) ulcer medications and expansion of personalized medicine approaches in ulcer treatment.
The growing geriatric population is expected to drive the growth of the gastric ulcers market in the coming years. The geriatric population refers to individuals typically aged 65 and older, who face unique health challenges associated with aging. This increase is primarily due to advancements in healthcare, which have led to longer life expectancies, alongside declining birth rates in many regions worldwide. Gastric ulcers are more common among the elderly due to the frequent use of NSAIDs and reduced mucosal protection, both of which heighten the risk of complications. For example, in January 2024, the Population Reference Bureau (PRB), a US-based non-profit organization, reported that the population of Americans aged 65 and older is expected to grow from 58 million in 2022 to 82 million by 2050, a 47% increase. Moreover, this age group's share of the total population is projected to rise from 17% to 23%, highlighting a significant aging trend in the U.S. population. These projections emphasize the growing need to address the healthcare needs of older adults across various sectors. As such, the increasing geriatric population is driving the growth of the gastric ulcers market.
Key companies in the gastric ulcer market are focusing on developing innovative products, such as new drug formulations, to improve treatment effectiveness and minimize side effects. New formulation drugs involve the creation of medications with novel combinations of active ingredients, delivery methods, or dosage forms aimed at enhancing their efficacy, safety, and patient adherence. For example, in June 2024, Akums Drugs and Pharmaceuticals Ltd., an India-based pharmaceutical manufacturer, introduced Rabeprazole + Levosulpiride SR Capsules. These capsules are designed to provide better relief for conditions like gastro-oesophageal reflux disease (GERD) and other gastrointestinal tract (GIT) disorders. The combination of a proton pump inhibitor and a prokinetic agent effectively treats gastrointestinal issues, including GERD and gastric ulcers. This formulation not only decreases gastric acid secretion but also improves gastric motility, offering comprehensive relief from symptoms such as heartburn and indigestion.
In May 2022, Dr. Reddy's Laboratories partnered with HK Inno.N. Corporation to supply and commercialize Tegoprazan, a novel molecule for gastrointestinal diseases, in India and six key emerging markets. Under this partnership, HK Inno.N. will manufacture and supply Tegoprazan, while Dr. Reddy's will oversee local clinical development, registration, marketing, and sales in the licensed territories. HK Inno.N. Corporation is a South Korea-based pharmaceutical company specializing in drugs for gastric ulcers.
Major companies operating in the gastric ulcers market are Pfizer Inc., Merck & Co Inc., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Co. Ltd, Amgen Inc., Boehringer Ingelheim, Viatris Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd, Cadila Pharmaceuticals, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Lupin Limited, Yuhan Corporation, Daewoong Pharmaceutical Co. Ltd, Cadila Healthcare Ltd, Novitium Pharma LLC
North America was the largest region in the gastric ulcers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric ulcers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the gastric ulcers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The gastric ulcers market consists of revenues earned by entities through barium swallow, H. pylori testing, and biopsy. The market value includes the value of related goods sold by the service provider or included within the service offering. The gastric ulcers market also includes sales of amoxicillin, clarithromycin, metronidazole, omeprazole, and lansoprazole. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Gastric Ulcers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on gastric ulcers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for gastric ulcers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gastric ulcers market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Drug Class: Proton Pump Inhibitors (PPI); H2 Antagonists; Antacids; Antibiotics; Cytoprotective Agents; Other Drug Classes
- 2) By Diagnosis: Stool Test; Endoscopy; Imaging Tests; Computed Tomography (CT) Scan; X-ray; Blood Tests; Other Diagnosis
- 3) By Route Of Administration: Oral; Parenteral; Other Route Of Administrations
- 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels
- 5) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End Users
- Subsegments:
- 1) By Proton Pump Inhibitors (PPI): Omeprazole; Lansoprazole; Pantoprazole; Esomeprazole; Rabeprazole
- 2) By H2 Antagonists: Ranitidine; Famotidine; Cimetidine; Nizatidine
- 3) By Antacids: Calcium Carbonate; Magnesium Hydroxide; Aluminum Hydroxide; Sodium Bicarbonate
- 4) By Antibiotics: Amoxicillin; Clarithromycin; Metronidazole; Tetracycline
- 5) By Cytoprotective Agents: Sucralfate; Misoprostol; Bismuth Subsalicylate
- 6) By Other Drug Classes: Prostaglandin Analogues; Prokinetic Agents; Herbal And Alternative Medications; Combination Therapies
- Companies Mentioned: Pfizer Inc.; Merck & Co Inc.; AbbVie Inc.; Sanofi S.A.; AstraZeneca plc
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Gastric Ulcers Market Characteristics
3. Gastric Ulcers Market Trends And Strategies
4. Gastric Ulcers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Gastric Ulcers Growth Analysis And Strategic Analysis Framework
- 5.1. Global Gastric Ulcers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Gastric Ulcers Market Growth Rate Analysis
- 5.4. Global Gastric Ulcers Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Gastric Ulcers Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Gastric Ulcers Total Addressable Market (TAM)
6. Gastric Ulcers Market Segmentation
- 6.1. Global Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Proton Pump Inhibitors (PPI)
- H2 Antagonists
- Antacids
- Antibiotics
- Cytoprotective Agents
- Other Drug Classes
- 6.2. Global Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Stool Test
- Endoscopy
- Imaging Tests
- Computed Tomography (CT) Scan
- X-ray
- Blood Tests
- Other Diagnosis
- 6.3. Global Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral
- Parenteral
- Other Route Of Administrations
- 6.4. Global Gastric Ulcers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Other Distribution Channels
- 6.5. Global Gastric Ulcers Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Specialty Clinics
- Homecare
- Other End Users
- 6.6. Global Gastric Ulcers Market, Sub-Segmentation Of Proton Pump Inhibitors (PPI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Omeprazole
- Lansoprazole
- Pantoprazole
- Esomeprazole
- Rabeprazole
- 6.7. Global Gastric Ulcers Market, Sub-Segmentation Of H2 Antagonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Ranitidine
- Famotidine
- Cimetidine
- Nizatidine
- 6.8. Global Gastric Ulcers Market, Sub-Segmentation Of Antacids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Calcium Carbonate
- Magnesium Hydroxide
- Aluminum Hydroxide
- Sodium Bicarbonate
- 6.9. Global Gastric Ulcers Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Amoxicillin
- Clarithromycin
- Metronidazole
- Tetracycline
- 6.10. Global Gastric Ulcers Market, Sub-Segmentation Of Cytoprotective Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Sucralfate
- Misoprostol
- Bismuth Subsalicylate
- 6.11. Global Gastric Ulcers Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Prostaglandin Analogues
- Prokinetic Agents
- Herbal And Alternative Medications
- Combination Therapies
7. Gastric Ulcers Market Regional And Country Analysis
- 7.1. Global Gastric Ulcers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Gastric Ulcers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Gastric Ulcers Market
- 8.1. Asia-Pacific Gastric Ulcers Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Gastric Ulcers Market
- 9.1. China Gastric Ulcers Market Overview
- 9.2. China Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Gastric Ulcers Market
- 10.1. India Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Gastric Ulcers Market
- 11.1. Japan Gastric Ulcers Market Overview
- 11.2. Japan Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Gastric Ulcers Market
- 12.1. Australia Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Gastric Ulcers Market
- 13.1. Indonesia Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Gastric Ulcers Market
- 14.1. South Korea Gastric Ulcers Market Overview
- 14.2. South Korea Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Gastric Ulcers Market
- 15.1. Western Europe Gastric Ulcers Market Overview
- 15.2. Western Europe Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Gastric Ulcers Market
- 16.1. UK Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Gastric Ulcers Market
- 17.1. Germany Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Gastric Ulcers Market
- 18.1. France Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Gastric Ulcers Market
- 19.1. Italy Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Gastric Ulcers Market
- 20.1. Spain Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Gastric Ulcers Market
- 21.1. Eastern Europe Gastric Ulcers Market Overview
- 21.2. Eastern Europe Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Gastric Ulcers Market
- 22.1. Russia Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Gastric Ulcers Market
- 23.1. North America Gastric Ulcers Market Overview
- 23.2. North America Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Gastric Ulcers Market
- 24.1. USA Gastric Ulcers Market Overview
- 24.2. USA Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Gastric Ulcers Market
- 25.1. Canada Gastric Ulcers Market Overview
- 25.2. Canada Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Gastric Ulcers Market
- 26.1. South America Gastric Ulcers Market Overview
- 26.2. South America Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Gastric Ulcers Market
- 27.1. Brazil Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Gastric Ulcers Market
- 28.1. Middle East Gastric Ulcers Market Overview
- 28.2. Middle East Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Gastric Ulcers Market
- 29.1. Africa Gastric Ulcers Market Overview
- 29.2. Africa Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Gastric Ulcers Market Competitive Landscape And Company Profiles
- 30.1. Gastric Ulcers Market Competitive Landscape
- 30.2. Gastric Ulcers Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
31. Gastric Ulcers Market Other Major And Innovative Companies
- 31.1. Abbott Laboratories
- 31.2. Novartis AG
- 31.3. GlaxoSmithKline plc
- 31.4. Takeda Pharmaceutical Co. Ltd
- 31.5. Amgen Inc.
- 31.6. Boehringer Ingelheim
- 31.7. Viatris Inc.
- 31.8. Daiichi Sankyo Company Limited
- 31.9. Eisai Co. Ltd
- 31.10. Cadila Pharmaceuticals
- 31.11. Dr. Reddy's Laboratories Ltd.
- 31.12. Hikma Pharmaceuticals PLC
- 31.13. Lupin Limited
- 31.14. Yuhan Corporation
- 31.15. Daewoong Pharmaceutical Co. Ltd
32. Global Gastric Ulcers Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Gastric Ulcers Market
34. Recent Developments In The Gastric Ulcers Market
35. Gastric Ulcers Market High Potential Countries, Segments and Strategies
- 35.1 Gastric Ulcers Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Gastric Ulcers Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Gastric Ulcers Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
